The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of ...

Nucala (mepolizumab) is a brand-name subcutaneous injection that comes in different forms. Depending on which form you’re prescribed, you or your doctor will administer the injection.

The FDA has approved a supplemental biologics application for Leqembi Iqlik subcutaneous injection for maintenance dosing in ...

After 18 months of intravenous administration of lecanemab (Leqembi), patients may now transition to subcutaneous delivery using the Leqembi Iqlik autoinjector.

The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance ...

While the approval of Leqembi Iqlik bodes well for Biogen and Eisai’s planned application for a subcutaneous induction ...

The subcutaneous version, dubbed Leqembi Iqlik, is approved as a maintenance treatment that can be used after an initial intravenous infusion regimen.

Physicians’ Clinic of Iowa Hematology and Oncology is the first in the state of Iowa to deliver Rituxan, a commonly used drug to treat lymphoma, as a subcutaneous injection.William Fusselman, MD ...

Eisai Co (ESAIY) and Biogen (BIIB) announced that Eisai has initiated the rolling submission of the Supplemental Biologics ...

The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release.Nivolumab and ...

The option for under-the-skin, subcutaneous injections could reduce the frequency of hospital visits. It could potentially allow for treatments to be closer to a patient's home. The subcutaneous ...